Surmodics, Inc.

NASDAQ:SRDX

39 (USD) • At close January 8, 2025
Bedrijfsnaam Surmodics, Inc.
Symbool SRDX
Munteenheid USD
Prijs 39
Beurswaarde 557,469,900
Dividendpercentage 0%
52-weken bereik 25.17 - 42.44
Industrie Medical Devices
Sector Healthcare
CEO Mr. Gary R. Maharaj
Website https://www.surmodics.com

An error occurred while fetching data.

Over Surmodics, Inc.

Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the

Vergelijkbare Aandelen

Bioventus Inc. logo

Bioventus Inc.

BVS

9.58 USD

BioLife Solutions, Inc. logo

BioLife Solutions, Inc.

BLFS

27.69 USD

Collegium Pharmaceutical, Inc. logo

Collegium Pharmaceutical, Inc.

COLL

33.34 USD

Humacyte, Inc. logo

Humacyte, Inc.

HUMA

4.68 USD

Castle Biosciences, Inc. logo

Castle Biosciences, Inc.

CSTL

32.72 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)